imagine new medicines arriving faster...a new ai model achieved up to 98.8% success optimizing molecules for drug creation. it's designed to speed up the whole process. amazing! Speaking of science — practice English with AI: https://app.speakfloe.com/#/onboarding/goals

Turns out the blood of people over 100 has some special proteins that look more like those of younger folks. This might point to ways to slow down aging!

used to be, weight loss was just calories in/out. now, early mouse studies show gut bacteria + low protein diets can turn white fat (storage) into beige fat (burn). interesting stuff.

10.7% weight loss! Genentech's phase 2 trial of petrelintide, a new obesity drug, had great results. That's a big jump over placebo. Promising new approach for metabolic health! Been using this to practice my English: https://app.speakfloe.com/#/onboarding/goals

Stem cells from baby teeth reduced motor & cognitive issues in rats with cerebral palsy (CP). CP affects 2-3 of 1000 births. Human trials are next! Promising even after symptoms start.

Phase 1 data says BV100, an antibiotic for drug-resistant infections, is safe. In Phase 2, it cut deaths in pneumonia patients by 50% compared to current treatments! 💪 Less scary infections for folks in hospitals.

What if AI could help rare disease patients find clinical trials faster? New study: an AI reviewed 1400+ charts in a week & found potential matches missed by normal methods. Speeds things up & could make access more fair. 🤔

scientists found a strong link between the epstein-barr virus (ebv) and multiple sclerosis (ms). it followed 10 million young adults and found that if you get ebv, you're way more likely to get ms later. this could change how we treat ms patients.

alzheimer's is scary. but scientists found that some brain cells have a built-in cleanup system for toxic tau protein (that's the bad stuff that builds up). and they identified CRL5SOCS4, a protein complex, that's key to tagging & destroying it. pretty neat.

Frailty used to be something we just accepted with age. Now a Phase 2 trial shows stem cell therapy (Laromestrocel) improved endurance & reduced frailty in older adults. Reversing aging markers? Quietly revolutionary.

ovarian cancer: a new drug (alnodesertib) with chemo helped 34 of 100 patients live 6 months without their cancer getting worse. chemo alone? 23 of 100. small, early trial, but worth watching.

Imagine a world where cancer treatment gets to people faster. FDA just approved a lung cancer therapy in record time! Tumors shrank in 76% of patients (a big jump from the usual 30-45%). This is why the lab work matters.

Schizophrenia's genetic risk is 73% unique, says a huge study. Bipolar & PTSD are far less so. Why care? Bc if genes overlap, maybe treatments should too. Time to rethink how we target mental illness.

Interesting early study: GLP-1 drugs (diabetes/weight loss meds) seem to cut down on ER visits & hospitalizations for people with chronic migraine. A 10-14% drop compared to other preventives.

Seaweed molecules 🤝 human skin molecules? Interesting! Early research shows some compounds in green seaweed (ulvan) are similar to what makes up our skin. Could be good for wound healing eventually.

high schoolers are building surgical robots! their prototype aims for submillimeter accuracy in spine surgery. that's a big deal since current methods have high error rates.

Menopause isn't just hot flashes. 3 in 4 women don't know it can *trigger* mental illness, like depression. We need to think of overall health, not just individual symptoms.

Remote surgery milestone: French surgeons successfully completed a gastric bypass in India in just 44 minutes using an Indian-made robot. Pretty neat.

Advanced kidney cancer got a hopeful boost. A new combo reduced disease progression/death by 30%—that's like 3 more people out of 10 seeing cancer slow down after immunotherapy stopped working. FDA is reviewing.

AI's impact: 2 drug molecules are now in clinical trials! This isn't replacing scientists, but accelerating our work to treat diseases faster. That's a win for patients!

First trimester bleeding is common (25%!). Bleeding + a dating ultrasound lagging by >5 days, *not* the bleeding alone, is what the study linked to increased risk of pregnancy loss. Something to know.

fda just approved a combo therapy for metastatic colorectal cancer (mCRC) with a specific BRAF mutation. the BREAKWATER trial saw a 51% reduction in risk of death! 🙌

billions spent targeting amyloid beta in alzheimer's, but new research suggests we've been looking at the wrong culprit. a "neglected cousin" peptide called P3 might form toxic clumps even faster 😬

New flu variants are spreading, so the WHO updated its vaccine recommendations for the '26-'27 flu season! It's important work to match vaccines to the real threats and prep for future pandemics.

Measles cases in the US have topped 1100 this year. 92% of those folks were unvaxxed or their vax status was unknown. That puts us at risk of losing our "measles eliminated" status. Important for herd immunity, folks!

Imagine needing a totally unique gene therapy... FDA might speed those up for ultra-rare diseases? So cool! It's about custom CRISPR treatments when only a few people worldwide have a condition.

New cell therapy (RB-1355) showed promise in early trials for aggressive lymphomas. In 13 patients, 2 who didn't respond to CAR-T (a different cell therapy) had complete remission. Small study, but encouraging!

Good news for wAIHA patients! Johnson & Johnson is seeking FDA approval for nipocalimab, a drug that, in trials, helped more people achieve stable hemoglobin (a key component of red blood cells). A possible new option to treat this rare anemia.

90% of prostate tumors had microplastics inside. 🤯 Turns out the cancerous tissue had WAY more plastic than healthy tissue. Still early, but could change how we think about cancer risk.

New hope for HER2-mutated non-small cell lung cancer (NSCLC) patients. Zongertinib is the first targeted treatment, showing a 76% response rate in early trials. A step towards more personalized cancer care.